prevalent in the world and also in Bangladesh. Overall HAV accounts for 25% of clinically evident acute hepatitis worldwide, HBV has infected over 2 billion people worldwide with a carrier of 350 million. [1] [2] [3] HEV accounts for about 50% of cases of sporadic acute hepatitis in India and epidemics have also been reported in Indian subcontinent, subSaharan Africa and Mexico. [4] [5] [6] The global prevalence varies from high >8% in Africa, Asia, Western Pacific region, intermediate 2-7% in South Eastern Europe and low <2.5 in Western Europe, North America and Australia. Prevalence of HCV is 1.8% in general population in USA, increasing up to 50% in unexplained cirrhosis and hepatocellular carcinoma (HCC) and is the most common cause of chronic liver disease. [4] [5] [6] The exact prevalence of hepatitis viruses varies from country to country and no exact data is available in Bangladesh. As the exact prevalence of hepatitis viruses are not known in Bangladesh, the present study was undertaken to asses the biochemical parameters in viral hepatitis which varies with respect to the different types of viral hepatitis. Fortunately, advances in serologic & molecular testing now allow accurate identification of the viral causes of both acute & chronic hepatitis. [7] [8] [9] [10] Moreover, the biochemical parameters in viral hepatitis can assess the degree of liver damage. So by estimating the biochemical parameters we can assess the severity of different types of hepatitis viruses. The routes of spread of these viruses are different & some of the viruses have got vaccines. So this study may help us to be aware of the most life threatening viruses.
Materials and Methods
This cross sectional study was carried out from January 2005 to December 2006 in Sir Salimullah Medical College and Hospital (SSMCH), Dhaka, Bangladesh. The study was conducted on a total number of 80 diagnosed viral hepatitis cases. All cases were selected by taking history & laboratory investigations following the exclusion or inclusion criteria.
Inclusion criteria were : 5 years of age, clinically selected patient, confirmed by serological viral marker. Exclusion criteria were: Hepatitis due to other causes, patient having other chronic liver diseases such as cirrhosis, liver failure, liver cancer, rheumatoid arthritis, thyroid dysfunction Study procedure: A total of 80 viral hepatitis patients with confirmed serological marker were included in this study from the outdoor and indoor patient department of Sir Salimullah Medical College Hospital. Each subject was explained verbally the nature & purpose of the study in order to get a free & fair written consent. Data were collected in appropriate questionnaire and laboratory investigations were done from the collected blood samples. Serum was separated by centrifugation at 3000-4000 rpm for 3-5 minutes. Estimations were carried out as early as possible. Serum level of alanine aminotransferase (S.ALT) was observed & found to be high in all patients of our study but highest in case of Hepatitis E followed by Hepatitis B and Hepatitis A, lowest in case of Hepatitis C. Higher level of S.ALT, similar to present study was found in another group of study. 12 Serum AST was found to be increased in all types of viral hepatitis although the increase was lesser than that of serum ALT. The increase was highest in Hepatitis E followed by Hepatitis B and Hepatitis A, lowest in Hepatitis C.
Results
Serum alkaline phosphate (ALP) was increased in Hepatitis B and was within normal limit in other groups. Highest in Hepatitis B is followed by Hepatitis E & Hepatitis A, lowest in case of Hepatitis C. Similar results was found in other studies. 13 Serum total protein values were not significantly altered in cases of all four types of Hepatitis. As most of the cases were in acute stage of the disease, so these unaltered values are expected. The increase of serum total protein in HCV might be due to the fact that HCV proteins usually come to hospital in chronic stage.
Serum albumin levels were found almost within normal range in most of the cases. 
Conclusion
Serum bilirubin was raised in all the types of viral hepatitis. Among them subjects with HEV showed marked raised level. On the other hand subject with HCV had the lowest level of serum bilirubin. Serum ALT and AST were also raised in all groups but were highest in subjects with HEV and the lowest level was observed in subjects with HCV. The reason behind the abnormal level can not be explored conclusively but within this limitation our study showed comparatively higher ALP value in subjects with HBV and then HEV and apparently no difference in HAV & HCV groups. Serum total protein, albumin, globulin and albumin-globulin ratio showed equivocal status. Prothrombin time was raised from the normal in all the groups. Highest increase was observed in HEV groups than HBV, HCV and HAV successively.
Considering the above statements it can be concluded that derangement of liver function in patients suffering from common types of viral hepatitis is more in HEV and HBV and comparatively less in HAV and HCV on the basis of evaluation of different biochemical parameters.
